Brief: Shilpa Medicare Says Shilpa Pharma Lifesciences, Unit 2 Clears Cofepris-Mexico GMP Inspection
23/07/2024 14:10
July 23 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* SHILPA PHARMA LIFESCIENCES, UNIT 2 CLEARED COFEPRIS-MEXICO
GMP
INSPECTION
* UNIT ISSUED GMP CERTIFICATION FROM COFEPRIS-MEXICO
Source text for Eikon: ID:nBSEt1QzJ
Further company coverage: SHME.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026